BioCaptiva is a biotechnology company focused on advancing liquid biopsy through its msX™ polymer technology, which directly captures cell-free DNA (cfDNA) from biological fluids with no additional reagents. The company emphasizes high-purity cfDNA yields, sample stability, and minimal pre-analytical processing to enable non-invasive genetic testing and expanded sequencing workflows. Based in the United Kingdom, BioCaptiva develops coatings adaptable to various substrates for large-volume, flow-through applications and ISO 13485-compliant production. Their work aims to improve cancer diagnostics and personalized medicine by enabling easier, more scalable cfDNA analysis.
No recent news for this company.